Factors influencing the endocytosis of immune complexes
- PMID: 6236677
Factors influencing the endocytosis of immune complexes
Abstract
The MPS plays an important role in the removal of both particulate and soluble immunogenic material from the circulation. E.IgG adhere to mononuclear phagocytes if the Fc portion of the IgG can interact with the phagocyte's Fc receptors (Fc gamma R). Simultaneous sensitization with IgG and C3b via complement activation enhances the effectiveness of binding and ingestion. E.IgM adhere mainly via C3b to C3b receptors (C3bR) of macrophages. Unstimulated macrophages do not ingest E.C3b. Stimulated macrophages, on the other hand, can ingest E.C3b. If soluble material cannot adhere to the surface of macrophages, it will be endocytosed in vitro via fluid-phase pinocytosis at the concentration that is present in the medium. If the material adheres to the cell's surface via its chemical properties or via specific receptors, it will be selectively concentrated at the cell's surface and endocytosed by adsorptive pinocytosis. Ingestion of IC via Fc gamma R and C3b depends on the ability of the antibodies to interact with Fc gamma R and their capacity to activate the complement system. IC-bound C3b enhances the adsorptive pinocytosis of IC. Soluble AIgG are also pinocytosed more effectively when C3b is bound to AIgG. The degree of endocytosis varies with the level of C3b sensitization. The highly effective C3b-mediated pinocytosis can be abolished by treating with trypsin to inactivate C3bR. This observation illustrates that C3b-mediated pinocytosis can replace Fc-mediated pinocytosis in unstimulated macrophages. When macrophages are stimulated in vivo, Fc-mediated pinocytosis increases significantly. Under these conditions, the binding of C3b no longer stimulates; instead, it sterically interferes with Fc-Fc gamma R interaction. In vivo, E.IgG are removed mainly by splenic macrophages. C4-deficient guinea pigs clear E.IgG less effectively than guinea pigs with an intact complement system. On the other hand, soluble IC and AIgG are removed from the circulation mainly by hepatic Kupffer cells. Complement depletion does not seem to influence the clearance rates of these soluble IC or AIgG. The different results obtained in vitro and in vivo and the finding that different effector organs are responsible for the removal of sensitized erythrocytes and soluble Ic in vivo, suggest that more reliable techniques have to be developed to measure IC clearance in patients with a supposedly deficient or saturated MPS.
Similar articles
-
Activation of complement by soluble IgG aggregates and their subsequent interaction with macrophages.Immunol Lett. 1987 Feb;14(3):217-24. doi: 10.1016/0165-2478(87)90104-0. Immunol Lett. 1987. PMID: 3570361
-
Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.Immunology. 1988 Jul;64(3):375-9. Immunology. 1988. PMID: 2970428 Free PMC article.
-
The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.Immunology. 1982 Sep;47(1):203-9. Immunology. 1982. PMID: 7118161 Free PMC article.
-
Heterogeneity of human and murine Fc gamma receptors.Ciba Found Symp. 1986;118:89-101. Ciba Found Symp. 1986. PMID: 2426048 Review.
-
Factors influencing immune complex localisation.Rheumatol Int. 1984;4(3):95-109. doi: 10.1007/BF00541177. Rheumatol Int. 1984. PMID: 6235569 Review.
Cited by
-
A novel mouse model expressing human forms for complement receptors CR1 and CR2.BMC Genet. 2020 Sep 9;21(1):101. doi: 10.1186/s12863-020-00893-9. BMC Genet. 2020. PMID: 32907542 Free PMC article.
-
Deficiency of complement component C3 is associated with accelerated removal of soluble 123I-labelled aggregates of IgG from the circulation.Clin Exp Immunol. 1992 Dec;90(3):394-400. doi: 10.1111/j.1365-2249.1992.tb05857.x. Clin Exp Immunol. 1992. PMID: 1458675 Free PMC article.
-
Complement Receptor 1: disease associations and therapeutic implications.Mol Immunol. 2009 Feb;46(5):761-72. doi: 10.1016/j.molimm.2008.09.026. Epub 2008 Nov 11. Mol Immunol. 2009. PMID: 19004497 Free PMC article. Review.
-
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.J Control Release. 2012 Feb 28;158(1):148-55. doi: 10.1016/j.jconrel.2011.10.021. Epub 2011 Oct 26. J Control Release. 2012. PMID: 22062689 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous